Innovation Pharmaceuticals Inc (IPIX)

[kfcyahoo]

Don't know why Dana Farber(DF) is no longer involved, could be a number of reasons. Did a check of DF Ovarian cancer studies and found 101 of them, appears 50 of them are still open.

I do find it curious as to why ctix has not specifically identified the site doing the ph 2 in Dallas(no problem identifying the phase 1 participants(with names) in Boston. I was hoping ph 2 was MD Anderson, but they appear to be based out of Houston, not Dallas.

Perhaps DF could not accommodate ctix's requested schedule(the ph 2 is scheduled for less than a year and is specific to ovarian cancer, while ph1 was solid tumors and took nearly 4 years. Ph 2 is also only 10 patients while ph 1 was 48.)

The company is obligated to answer all questions.